Home › Funds › Vivo Capital, LLC › OLMA
Vivo Capital, LLC position in OLMA
OLEMA PHARMACEUTICALS INC · Health Care
Vivo Capital, LLC reported holding 671,843 shares of OLMA (OLEMA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$5.8M, representing 0.66% of its reported portfolio and ranking #34 among its reported holdings. Vivo Capital, LLC has disclosed OLMA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Vivo Capital, LLC's OLMA position evolved
Vivo Capital, LLC first disclosed a stake in OLMA in Q3 2023 at 1,873,704 shares (US$23.1M). The position peaked in Q4 2023 at 1,873,704 shares, worth US$26.3M. Across 13 filings, Vivo Capital, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 10 time(s). The most recent filing (Q3 2026) shows 671,843 shares valued at US$5.8M. Notable position changes include a 55% trim in Q4 2025 (shares fell 40% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.87M | $23.14M | New |
| Q4 2023 | 1.87M | $26.29M | Hold |
| Q1 2024 | 1.87M | $21.21M | Hold |
| Q2 2024 | 1.87M | $20.27M | Hold |
| Q3 2024 | 1.51M | $17.98M | Reduce |
| Q4 2024 | 1.51M | $8.78M | Hold |
| Q1 2025 | 1.51M | $5.66M | Hold |
| Q2 2025 | 1.51M | $6.41M | Hold |
| Q3 2025 | 1.51M | $14.74M | Hold |
| Q4 2025 | 671.84K | $16.80M | Reduce |
| Q1 2026 | 671.84K | $10.02M | Hold |
| Q2 2026 | 671.84K | $8.40M | Hold |
| Q3 2026 | 671.84K | $5.80M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About OLMA and 13F data
OLMA (OLEMA PHARMACEUTICALS INC) is a Health Care company. 38 other funds we track also report a position in OLMA — the largest reported positions include Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), BVF INC/IL (US$66.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding OLMA
- Paradigm Biocapital Advisors LP 8.67M sh · $108.47M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 7.09M sh · $88.64M · Q2 2026
- BVF INC/IL 5.30M sh · $66.25M · Q2 2026
- Siren, L.L.C. 4.86M sh · $41.96M · Q3 2026
- Logos Global Management LP 3.21M sh · $40.14M · Q2 2026
- Cormorant Asset Management, LP 2.15M sh · $26.90M · Q2 2026
- Lightspeed Management Company, L.L.C. 1.36M sh · $16.95M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 1.20M sh · $15.01M · Q2 2026
- Defilade Capital Management, L.P. 924.76K sh · $11.57M · Q2 2026
More on Vivo Capital, LLC
FAQ
How long has Vivo Capital, LLC held OLMA?
Vivo Capital, LLC has disclosed OLMA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Vivo Capital, LLC's current position in OLMA?
As of Q3 2026, Vivo Capital, LLC holds 671.84K shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $5.80M, representing 0.66% of its reported portfolio and ranking #34.
Has Vivo Capital, LLC been buying or selling OLMA?
In the latest 13F filing (Q3 2026), Vivo Capital, LLC held unchanged its position in OLMA. The position peaked in Q4 2023 at 1.87M shares.
Which other funds hold OLMA?
Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, among 38 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.